Treatment of Cutaneous Larva Migrans with albendazole: preliminary report

Twenty three patients with Cutaneous Larva Migrans syndrome were prospectively treated with 400 mg/day of Albendazole for 3 consecutive days. Clinical response, compliance and tolerance was excellent. Patients were asymptomatic within the first 72 hours of treatment and recurrences did not occurred....

Full description

Bibliographic Details
Main Authors: Jaime R. Torres R., Angel R. Orihuela, David Garcia, Salha Abdul-Hadi
Format: Article
Language:English
Published: Universidade de São Paulo 1989-02-01
Series:Revista do Instituto de Medicina Tropical de São Paulo
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651989000100012&lng=en&tlng=en